Depressive subtypes generally have been neglected in research on treatment efficacy. We studied a sample of 699 severe unipolar depressed patients to detect any association between depressive features and treatment resistance.
Methods
Participants were divided into psychotic (PSY, n = 90), melancholic (MEL, n = 430) and non-melancholic (n = 179) subjects according to clinical features. Formal diagnostic criteria (Mini International Neuropsychiatric Interview items), and items from 17-item Hamilton Rating Scale for Depression (HRSD17) were compared across groups. Non-responders were defined by a HRSD17 cut-off score of ≥17 after the last adequate antidepressant treatment. Treatment-resistant depression (TRD) was defined as the failure to respond to ≥2 adequate antidepressant trials. Non-linear regression models were designed to detect associations between depressive subtypes and TRD.
Results
PSY and MEL patients appeared to be more severely affected and to share some “core” melancholic symptoms. Both PSY and MEL patients reported a higher rate of seasonality. However, we found no clinical or illness course variable associated with TRD.
Conclusions
Our results indicate that psychotic and melancholic depression share some “core” melancholia symptoms, while no distinguishing psychopathological feature appears to be associated with TRD in severely depressed patients.
Diagnostic and statistical manual of mental disorders, 3rd ed.Washington, DC:American Psychiatric Association; 1980.
2.
AkiskalHS, McKinneyWTJr.Depressive disorders: toward a unified hypothesis. Science. 1973;182:20–29.
3.
AkiskalHS, McKinneyWTJr.Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame. Arch Gen Psychiatry. 1975;32:285–305.
4.
ShankmanSA, KleinDN.Dimensional diagnosis of depression: adding the dimension of course to severity, and comparison to the DSM. Compr Psychiatry. 2002;43:420–426.
5.
JuddLL, SchettlerPJ, AkiskalHS.The prevalence, clinical relevance, and public health significance of subthreshold depressions. Psychiatr Clin North Am. 2002;25:685–698.
6.
QuinnC, HarrisA, KempA.The Interdependence of subtype and severity: contributions of clinical and neuropsychological features to melancholia and nonmelancholia in an outpatient sample. J Int Neuropsychol Soc. 2012;18:361–369.
7.
SchatzbergAF, RothschildAJ.Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry. 1992;149:733–745.
8.
ParkerG.Classifying depression: should paradigms lost be regained? Am J Psychiatry. 2000;157:1195–1203.
9.
ParkerG, FinkM, ShorterE, . Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder. Am J Psychiatry. 2010;167:745–747.
10.
ParkerG, Hadzi-PavlovicD.Melancholia. A disorder of movement and mood. Cambridge, United Kingdom: Cambridge University Press; 1996.
11.
ParkerG.Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand Suppl. 2007:21–30.
12.
ParkerG, Hadzi-PavlovicD, WilhelmK, . Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry. 1994;164:316–326.
13.
ParkerG, Hadzi-PavlovicD, BrodatyH, . Subtyping depression, II. Clinical distinction of psychotic depression and non-psychotic melancholia. Psychol Med. 1995;25:825–832.
14.
SobinC, SackeimHA.Psychomotor symptoms of depression. Am J Psychiatry. 1997;154:4–17.
CarrollBJ.Neurobiologic dimensions of depression and mania. In: AngstJ, ed. The origins of depression: current concepts and approaches.Berlin, Germany: Springer Verlag; 1983:163–186.
17.
FountoulakisKN, IacovidesA, GerasimouG, . The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:537–546.
18.
TaylorMA, FinkM.Melancholia. The diagnosis, pathophysiology, and treatment of depressive illness. Cambridge, United Kingdom: Cambridge University Press; 2006.
19.
ThaseME, KupferDJ, UlrichRF.Electroencephalographic sleep in psychotic depression. A valid subtype? Arch Gen Psychiatry. 1986;43:886–893.
20.
BrownRP, StollPM, StokesPE, . Adrenocortical hyperactivity in depression: effects of agitation, delusions, melancholia, and other illness variables. Psychiatry Res. 1988;23:167–178.
21.
NelsonJC, DavisJM.DST studies in psychotic depression: a meta-analysis. Am J Psychiatry. 1997;154:1497–1503.
22.
KellerJ, FloresB, GomezRG, . Cortisol circadian rhythm alterations in psychotic major depression. Biol Psychiatry. 2006;60:275–281.
23.
ContrerasF, MenchonJM, UrretavizcayaM, . Hormonal differences between psychotic and nonpsychotic melancholic depression. J Affect Disord. 2007;100:65–73.
24.
PotashJB.Carving chaos: genetics and the classification of mood and psychotic syndromes. Harv Rev Psychiatry. 2006;14:47–63.
25.
FrankE, KupferDJ, HamerT, . Maintenance treatment and psychobiologic correlates of endogenous subtypes. J Affect Disord. 1992;25:181–189.
26.
ParkerG, Hadzi-PavlovicD, BrodatyH, . Predicting the course of melancholic and nonmelancholic depression. A naturalistic comparison study. J Nerv Ment Dis. 1992;180:693–702.
27.
ThaseME, FriedmanES.Is psychotherapy an effective treatment for melancholia and other severe depressive states?J Affect Disord.1999;54:1–19.
28.
ManschreckTC, KhanNL.Recent advances in the treatment of delusional disorder. Can J Psychiatry. 2006;51:114–119.
29.
CoryellW, TsuangMT.Primary unipolar depression and the prognostic importance of delusions. Arch Gen Psychiatry. 1982;39:1181–1184.
SpikerDG, WeissJC, DealyRS, . The pharmacological treatment of delusional depression. Am J Psychiatry. 1985;142:430–436.
32.
ParkerG, RoyK, Hadzi-PavlovicD, . Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord. 1992;24:17–24.
33.
ChanCH, JanicakPG, DavisJM, . Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. J Clin Psychiatry. 1987;48:197–200.
34.
CoryellW, TurnerR.Outcome with desipramine therapy in subtypes of nonpsychotic major depression. J Affect Disord. 1985;9:149–154.
35.
AngstJ, StablM.Efficacy of moclobemide in different patient groups: a meta-analysis of studies. Psychopharmacology (Berl). 1992;106:(suppl)S109–S113.
36.
PeselowED, SanfilipoMP, DifigliaC, . Melancholic/endogenous depression and response to somatic treatment and placebo. Am J Psychiatry. 1992;149:1324–1334.
37.
PerryPJ.Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. J Affect Disord. 1996;39:1–6.
38.
MallinckrodtCH, WatkinJG, LiuC, . Duloxetine in the treatment of major depressive disorder: a comparison of efficacy in patients with and without melancholic features. BMC Psychiatry. 2005;5:1.
39.
McGrathPJ, KhanAY, TrivediMH, . Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. J Clin Psychiatry. 2008;69:1847–1855.
40.
SoueryD, OswaldP, MassatI, . Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry. 2007;68:1062–1070.
41.
CarrollBJ.Bringing back melancholia. Bipolar Disord. 2012;14:1–5.
42.
IoannidisJP.Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? Philos Ethics Humanit Med. 2008;3:14.
43.
PigottHE, LeventhalAM, AlterGS, . Efficacy and effectiveness of antidepressants: current status of research. Psychother Psychosom. 2010;79:267–279.
44.
Diagnostic and statistical manual of mental disorders, 4th ed.Washington, DC:American Psychiatric Association; 1994.
45.
PosternakMA, ZimmermanM.How accurate are patients in reporting their antidepressant treatment history?J Affect Disord.2003;75:115–124.
46.
SheehanDV, LecrubierY, SheehanKH, . The Mini-International Neuropsychiatric Interview (M. I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:(suppl 20)22–33;quiz 4-57.
47.
HamiltonM.A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
48.
European Agency for the Evaluation of Medicinal Products. Note for guidance on clinical investigation of medicinal products in the treatment of depression. http://www.emea.europa.eu/pdfs/human/ewp/051897en.pdf. Published April 25, 2002. Accessed January 29, 2013.
49.
StatSoftI, STATISTICA for Windows. 1995.
50.
Diagnostic and statistical manual of mental disorders, 4th ed, text rev. Washington DC: American Psychiatric Association; 2000.
51.
CoryellW, WinokurG, SheaT, . The longterm stability of depressive subtypes. Am J Psychiatry. 1994;151:199–204.
52.
CoryellW, LeonA, WinokurG, . Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry. 1996;153:483–489.
53.
GlassmanAH, RooseSP.Delusional depression. A distinct clinical entity? Arch Gen Psychiatry. 1981;38:424–427.
54.
FrancesA, BrownRP, KocsisJH, . Psychotic depression: a separate entity?Am J Psychiatry. 1981;138:831–833.
55.
ParkerG, Hadzi-PavlovicD, HickieI, . Psychotic depression: a review and clinical experience. Aust N Z J Psychiatry. 1991;25:169–180.
56.
SoueryD, ZaninottoL, CalatiR, . Phenomenology of psychotic mood disorders: lifetime and major depressive episode features. J Affect Disord. 2011;135:241–250.
57.
HildebrandtMG, StageKB, Kragh-SoerensenP; Danish University Antidepressant Group. Gender differences in severity, symptomatology and distribution of melancholia in major depression. Psychopathology. 2003;36:204–212.
58.
KhanAY, CarrithersJ, PreskornSH, . Clinical and demographic factors associated with DSM-IV melancholic depression. Ann Clin Psychiatry. 2006;18:91–98.
59.
GoldPW, ChrousosGP.Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry. 2002;7:254–275.
60.
AngstJ, GammaA, BenazziF, . Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality. Acta Psychiatr Scand Suppl. 2007:72–84.
61.
CoryellW.The facets of melancholia. Acta Psychiatr Scand Suppl. 2007:31–36.
62.
WinthorstWH, PostWJ, MeestersY, . Seasonality in depressive and anxiety symptoms among primary care patients and in patients with depressive and anxiety disorders; results from the Netherlands Study of Depression and Anxiety. BMC Psychiatry. 2011;11:198.
63.
GaudianoBA, BeeversCG, MillerIW.Differential response to combined treatment in patients with psychotic versus nonpsychotic major depression. J Nerv Ment Dis. 2005;193:625–628.
64.
HaraldB, GordonP.Meta-review of depression subtyping models. J Affect Disord. 2012;139:126–140.
65.
LuxV, AggenSH, KendlerKS.The DSM-IV definition of severity of major depression: inter-relationship and validity. Psychol Med. 2010;40:1691–1701.
